As ZEISS passes a major milestone for SMILE lenticule extraction procedures globally, the company revealed it now has the first such treatment for hyperopia available in European markets at ESCRS 2024. The company’s medical technology division has been showcasing its...
Patients with a rare inherited disease affecting their sight have experienced quick, sometimes substantial vision improvements after being involved in a gene therapy trial. The rare inherited condition can cause people to lose much of their sight early in childhood....
LINDEN CHEN discusses the critical role of early intervention and collaboration for improved paediatric eye health outcomes, and how the StEPS service achieves this. In my current role as the StEPS coordinator for the Sydney Children’s Hospital Network (SCHN), I...
Orthoptics Australia president A/PROF AMANDA FRENCH reviews the 2024-25 Federal Budget and what it means to the allied health sector. Orthoptics Australia (OA) welcomes the Budget announcements for the eye health sector including new and amended Medicare Benefits Schedule (MBS)...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited